JP2020519308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519308A5 JP2020519308A5 JP2020512919A JP2020512919A JP2020519308A5 JP 2020519308 A5 JP2020519308 A5 JP 2020519308A5 JP 2020512919 A JP2020512919 A JP 2020512919A JP 2020512919 A JP2020512919 A JP 2020512919A JP 2020519308 A5 JP2020519308 A5 JP 2020519308A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- amino acid
- acid sequence
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 102000040430 polynucleotide Human genes 0.000 claims 3
- 108091033319 polynucleotide Proteins 0.000 claims 3
- 239000002157 polynucleotide Substances 0.000 claims 3
- 239000013604 expression vector Substances 0.000 claims 2
- 101000771075 Homo sapiens Cyclic nucleotide-gated cation channel beta-1 Proteins 0.000 claims 1
- 101001004924 Homo sapiens Transforming growth factor beta activator LRRC32 Proteins 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 102000052917 human LRRC32 Human genes 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022122483A JP2022169549A (ja) | 2017-05-11 | 2022-08-01 | ＧＡＲＰ－ＴＧＦ－β抗体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1707561.5 | 2017-05-11 | ||
| GBGB1707561.5A GB201707561D0 (en) | 2017-05-11 | 2017-05-11 | GARP-TGF-beta antibodies |
| PCT/EP2018/062251 WO2018206790A1 (en) | 2017-05-11 | 2018-05-11 | GARP-TGF-β ANTIBODIES |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122483A Division JP2022169549A (ja) | 2017-05-11 | 2022-08-01 | ＧＡＲＰ－ＴＧＦ－β抗体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020519308A JP2020519308A (ja) | 2020-07-02 |
| JP2020519308A5 true JP2020519308A5 (enExample) | 2021-06-10 |
| JPWO2018206790A5 JPWO2018206790A5 (enExample) | 2022-01-25 |
| JP7118135B2 JP7118135B2 (ja) | 2022-08-15 |
Family
ID=59201573
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512919A Active JP7118135B2 (ja) | 2017-05-11 | 2018-05-11 | ＧＡＲＰ－ＴＧＦ－β抗体 |
| JP2022122483A Withdrawn JP2022169549A (ja) | 2017-05-11 | 2022-08-01 | ＧＡＲＰ－ＴＧＦ－β抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022122483A Withdrawn JP2022169549A (ja) | 2017-05-11 | 2022-08-01 | ＧＡＲＰ－ＴＧＦ－β抗体 |
Country Status (35)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057881A1 (en) * | 2001-12-28 | 2003-07-17 | Chugai Seiyaku Kabushiki Kaisha | Method of stabilizing protein |
| US11046782B2 (en) * | 2016-03-30 | 2021-06-29 | Musc Foundation For Research Development | Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination |
| SG11202009970VA (en) | 2019-08-28 | 2021-04-29 | Chugai Pharmaceutical Co Ltd | Cross-Species Anti-Latent TGF-Beta 1 Antibodies And Methods Of Use |
| WO2021079958A1 (ja) | 2019-10-25 | 2021-04-29 | 第一三共株式会社 | 抗ｇａｒｐ抗体と免疫調節剤の組み合わせ |
| CN115190812A (zh) * | 2020-01-11 | 2022-10-14 | 供石公司 | TGFβ抑制剂及其用途 |
| CN115243724B (zh) | 2020-02-19 | 2025-10-21 | 纳米医疗有限公司 | 可用于治疗癌症的经调配和/或共调配的含有TFGβ拮抗剂前药的脂质体组合物和其方法 |
| US20230192867A1 (en) * | 2020-05-15 | 2023-06-22 | Bristol-Myers Squibb Company | Antibodies to garp |
| JP2023552919A (ja) * | 2020-11-11 | 2023-12-19 | ベルサピューティクス インコーポレイテッド | Ｗｎｔ受容体ｒｙｋに対する抗体バリアント |
| IL303349A (en) * | 2020-12-02 | 2023-08-01 | Shanghai Henlius Biotech Inc | ANTI-GARP/TGFβ ANTIBODIES AND METHODS OF USE |
| KR20230169936A (ko) * | 2021-01-18 | 2023-12-18 | 상하이 제민케어 파마슈티칼 컴퍼니 리미티드 | Garp 단백질 항체 및 이의 적용 |
| EP4526330A1 (en) | 2022-05-18 | 2025-03-26 | Vestaron Corporation | Pesticidal actx peptide variants |
| EP4558823A1 (en) | 2022-07-22 | 2025-05-28 | Institut National de la Santé et de la Recherche Médicale | Garp as a biomarker and biotarget in t-cell malignancies |
| EP4561612A1 (en) | 2022-07-29 | 2025-06-04 | Abbvie Biotherapeutics Inc. | Anti-garp-tgf-beta1/pd-1 combination therapy |
| KR20250133913A (ko) | 2023-01-09 | 2025-09-09 | 베이징 투오 지에 바이오파마수티컬 컴퍼니 리미티드 | TGFβ1 결합 분자, GARP-TGFβ1 결합 분자 및 이의 의학적 용도 |
| WO2024164807A1 (zh) * | 2023-02-06 | 2024-08-15 | 贝达药业股份有限公司 | 多特异性抗体及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| AU3178993A (en) | 1991-11-25 | 1993-06-28 | Enzon, Inc. | Multivalent antigen-binding proteins |
| NZ298145A (en) | 1994-12-29 | 1998-08-26 | Yamanouchi Pharma Co Ltd | Monoclonal antibodies having inhibitory effect on type ii phospholipase a2, proteins forming part thereof, cells producing them, dna encoding them, recombinant vector comprising the dna and medicament |
| US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
| ES2304069B1 (es) * | 2003-08-22 | 2009-08-12 | Proyecto De Biomedicina Cima, S.L. | Peptidos con capacidad de unirse al factor transformante de crecimiento beta 1 (tgf-b1). |
| US20070048785A1 (en) | 2004-06-09 | 2007-03-01 | Lin Laura L | Anti-IL-13 antibodies and complexes |
| WO2006103639A2 (en) | 2005-03-31 | 2006-10-05 | Case Western Reserve University | Methods and reagents for identifying/isolating t regulatory (treg) cells and for treating individuals |
| EP2001509A1 (en) | 2006-04-03 | 2008-12-17 | Medizinische Hochschule Hannover | Pharmaceuticals for influencing the reaction of the human immune system |
| WO2009073163A1 (en) | 2007-12-03 | 2009-06-11 | American Type Culture Collection (Atcc) | Avian influenza antibodies, compositions, and methods thereof |
| GB2461546B (en) | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| WO2010022341A1 (en) | 2008-08-21 | 2010-02-25 | The United State Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of enriching and using regulatory t cells |
| KR101492052B1 (ko) | 2012-06-26 | 2015-02-10 | (주)대창솔루션 | 액화가스 운반용 탱크 |
| JP6391574B2 (ja) * | 2012-08-31 | 2018-09-26 | アルゲン−エックス ビーブイビーエー | 種間標的内交差反応性を有する抗体分子を産生する方法 |
| CA2911514A1 (en) | 2013-05-06 | 2014-11-13 | Scholar Rock, Inc. | Compositions and methods for growth factor modulation |
| EP3786187A1 (en) * | 2013-08-01 | 2021-03-03 | Université catholique de Louvain | Antibody binding a complex of human glycoprotein a repetitions predominant (garp) and latent tgf-beta-1 |
| EP2832747A1 (en) * | 2013-08-01 | 2015-02-04 | Université Catholique de Louvain | Anti-GARP protein and uses thereof |
| WO2016125017A1 (en) | 2015-02-03 | 2016-08-11 | Universite Catholique De Louvain | Anti-garp protein and uses thereof |
| JP6878283B2 (ja) * | 2015-09-24 | 2021-05-26 | 第一三共株式会社 | 抗ｇａｒｐ抗体 |
| MX2019000514A (es) * | 2016-07-14 | 2019-07-12 | Scholar Rock Inc | Anticuerpos de tgfb, métodos, y usos. |
-
2017
- 2017-05-11 GB GBGB1707561.5A patent/GB201707561D0/en not_active Ceased
-
2018
- 2018-05-11 NZ NZ758647A patent/NZ758647A/en unknown
- 2018-05-11 KR KR1020197036577A patent/KR102664663B1/ko active Active
- 2018-05-11 PT PT187285242T patent/PT3606961T/pt unknown
- 2018-05-11 MY MYPI2019006528A patent/MY199335A/en unknown
- 2018-05-11 LT LTEPPCT/EP2018/062251T patent/LT3606961T/lt unknown
- 2018-05-11 EP EP18728524.2A patent/EP3606961B8/en active Active
- 2018-05-11 MX MX2019013490A patent/MX385670B/es unknown
- 2018-05-11 BR BR112019023735A patent/BR112019023735A8/pt unknown
- 2018-05-11 HR HRP20220787TT patent/HRP20220787T1/hr unknown
- 2018-05-11 HU HUE18728524A patent/HUE059237T2/hu unknown
- 2018-05-11 EP EP22168997.9A patent/EP4086286A1/en not_active Withdrawn
- 2018-05-11 PL PL18728524.2T patent/PL3606961T3/pl unknown
- 2018-05-11 DK DK18728524.2T patent/DK3606961T3/da active
- 2018-05-11 RS RS20220600A patent/RS63361B1/sr unknown
- 2018-05-11 CA CA3061841A patent/CA3061841C/en active Active
- 2018-05-11 RU RU2019140602A patent/RU2767784C2/ru active
- 2018-05-11 AU AU2018265241A patent/AU2018265241B2/en active Active
- 2018-05-11 US US15/977,449 patent/US10479829B2/en active Active
- 2018-05-11 IL IL270236A patent/IL270236B2/en unknown
- 2018-05-11 SG SG10201914130VA patent/SG10201914130VA/en unknown
- 2018-05-11 IL IL305613A patent/IL305613A/en unknown
- 2018-05-11 ES ES18728524T patent/ES2921015T3/es active Active
- 2018-05-11 KR KR1020247014708A patent/KR20240065192A/ko active Pending
- 2018-05-11 WO PCT/EP2018/062251 patent/WO2018206790A1/en not_active Ceased
- 2018-05-11 PE PE2019002382A patent/PE20200618A1/es unknown
- 2018-05-11 SI SI201830702T patent/SI3606961T1/sl unknown
- 2018-05-11 CR CR20190561A patent/CR20190561A/es unknown
- 2018-05-11 EP EP23189977.4A patent/EP4282430A3/en active Pending
- 2018-05-11 JP JP2020512919A patent/JP7118135B2/ja active Active
- 2018-05-11 SM SM20220284T patent/SMT202200284T1/it unknown
- 2018-05-11 CN CN201880046262.8A patent/CN110945027B/zh active Active
- 2018-05-11 UA UAA201911783A patent/UA125534C2/uk unknown
-
2019
- 2019-05-10 US US16/409,679 patent/US10875914B2/en active Active
- 2019-11-08 CL CL2019003211A patent/CL2019003211A1/es unknown
- 2019-11-08 DO DO2019000285A patent/DOP2019000285A/es unknown
- 2019-11-11 PH PH12019502526A patent/PH12019502526A1/en unknown
- 2019-11-27 US US16/698,833 patent/US10793627B2/en active Active
- 2019-12-04 CO CONC2019/0013669A patent/CO2019013669A2/es unknown
- 2019-12-10 EC ECSENADI201987742A patent/ECSP19087742A/es unknown
-
2020
- 2020-11-12 US US17/096,931 patent/US20210324061A1/en not_active Abandoned
-
2021
- 2021-09-30 AU AU2021240255A patent/AU2021240255A1/en not_active Abandoned
-
2022
- 2022-06-29 CY CY20221100444T patent/CY1125674T1/el unknown
- 2022-08-01 JP JP2022122483A patent/JP2022169549A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519308A5 (enExample) | ||
| JP2017169559A5 (enExample) | ||
| JP2020504101A5 (enExample) | ||
| HRP20220787T1 (hr) | Protutijela protiv garp-tgf-beta | |
| JP2018526981A5 (enExample) | ||
| JP2020184996A5 (enExample) | ||
| JP2019201643A5 (enExample) | ||
| JP2009537608A5 (enExample) | ||
| JP2020508655A5 (enExample) | ||
| JP2019525738A5 (enExample) | ||
| RU2009128064A (ru) | Антитела к cd44 | |
| JP2020525032A5 (enExample) | ||
| JP2013545455A5 (enExample) | ||
| HRP20201993T1 (hr) | Protutijela protiv pd-1 | |
| JP2018183173A5 (enExample) | ||
| JP2012501670A5 (enExample) | ||
| JP2009523459A5 (enExample) | ||
| JP2016512551A5 (enExample) | ||
| JP2014534242A5 (enExample) | ||
| FI3310812T3 (fi) | Anti-her2-vasta-aineita ja käyttömenetelmiä | |
| JP2010532764A5 (enExample) | ||
| JPWO2019129221A5 (enExample) | ||
| JP2016511277A5 (enExample) | ||
| JP2012525829A5 (enExample) | ||
| JP2012501669A5 (enExample) |